PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-91

  1. 224 Posts.
    lightbulb Created with Sketch. 24
    After market, someone is trying their a$$ off to bring this down and succeeding. Still very happy with this announcement
    https://hotcopper.com.au/data/attachments/5176/5176120-a1c048671721d7aa5f798b3124e6c6e9.jpg
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.